Date | Time | Source | Headline | Symbol | Company |
07/03/2024 | 1:00PM | iHub Newswire | FeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent | | |
10/11/2013 | 4:46PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/11/2013 | 4:37PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/02/2013 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/02/2013 | 6:00AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:43PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:42PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:40PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:39PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:38PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:36PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:35PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:34PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:33PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:31PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:30PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:29PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:28PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:27PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:24PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:23PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:22PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:19PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:17PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:14PM | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:13PM | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 4:05PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 8:58AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 6:34AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/01/2013 | 6:21AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |